Oncogenes and clinical oncology.

Area of Science:

• Molecular biology of human cancer
• Cancer genetics
• Gene regulation in malignancy

Background:

• Normal genes can become oncogenes, promoting cancer when mutated or overexpressed.
• Tumor suppressor genes, when lost or inactivated, contribute to cancer development.
• Cancer arises from a multistep process involving defects in both oncogenes and tumor suppressor genes.

Purpose of the Study:

• To summarize recent advances in understanding the molecular biology of human cancer.
• To highlight the roles of oncogenes and tumor suppressor genes in cancer development.
• To discuss new insights into specific cancers like leukemia and colon cancer.

Main Methods:

• Review of recent scientific literature on human cancer molecular biology.
• Analysis of genetic alterations (mutations, overexpression, translocations) in cancer.
• Examination of specific gene fusions and their roles in leukemia.

Main Results:

• Oncogene activation and tumor suppressor gene inactivation are key to cancer.
• Multistep genetic defects characterize malignant progression, e.g., colon cancer.
• Specific chromosomal abnormalities create fusion genes in leukemia (CML, APL).

Conclusions:

• Understanding oncogenes and tumor suppressor genes is crucial for cancer prognosis.
• Fusion genes in leukemia, like in APL, offer therapeutic targets.
• Targeting specific molecular pathways provides novel treatment strategies for cancer.